Evidence map›Paper›PMID 36097162›Full record

ArticleNature communications2022

SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus.

Emilie Branche, Ying-Ting Wang, Karla M Viramontes, Joan M Valls Cuevas, Jialei Xie, Fernanda Ana-Sosa-Batiz, Norazizah Shafee, Sascha H Duttke, Rachel E McMillan, Alex E Clark and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cystatin from the helminthFrontiers in immunology · 2024
    Article
  17. Article
  18. Article
  19. Enhancers associated with unstable RNAs are rare in plants.bioRxiv : the preprint server for biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Emilie BrancheCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Ying-Ting WangCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Karla M ViramontesCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Joan M Valls CuevasCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Jialei XieDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Fernanda Ana-Sosa-BatizCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Norazizah ShafeeCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.ORCID 0000-0002-6877-7612
Sascha H DuttkeSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, 99163, USA.ORCID 0000-0003-4717-000X
Rachel E McMillanDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Alex E ClarkDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID 0000-0003-1687-416X
Michael N NguyenCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.ORCID 0000-0002-4184-7078
Aaron F GarretsonDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID 0000-0003-3855-4482
Jan J CramesCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Nathan J SpannDepartment of Cellular and Molecular Medicine, School of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Zhe ZhuDepartment of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA, 92093, USA.ORCID 0000-0002-5385-948X
Jeremy N RichDepartment of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Deborah H SpectorDepartment of Cellular and Molecular Medicine, School of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Christopher BennerDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
Sujan ShrestaCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA. sujan@lji.org.ORCID 0000-0003-2906-8474
Aaron F CarlinDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA. acarlin@health.ucsd.edu.ORCID 0000-0002-1669-8066
La Jolla Institute for Immunology · USUniversity of California San Diego · USUC San Diego Health System · USUniversity of California System · USWashington State University · US

Funding

Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Dynamic Complexity of Brain Tumor Stem Cells (R35CA197718)R35CA197718 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RICH, JEREMY N · 2015 to 2021
$6.4M
Development of a Replicon RNA-based Vaccine against Dengue and ZikaR01AI163188 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2021 to 2025
$3.6M
Maternal Antibody-Mediated Enhancement of Dengue PathogenesisR01AI153500 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2021 to 2025
$3.1M
Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662)R01CA238662 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAY, STEVE A, RICH, JEREMY N · 2020 to 2024
$2.8M
Molecular basis of Zika-induced microcephalyR01NS106387 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G · 2018 to 2021
$2.2M
IRF-3/5/7-Independent Antiviral ImmunityR01AI116813 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2016 to 2019
$1.9M
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2 (R01NS103434)R01NS103434 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RICH, JEREMY N · 2017 to 2021
$1.7M
Uncovering how transcription and chromatin 3D structure impact one another during cellular activationR01GM134366 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENNER, CHRISTOPHER W · 2019 to 2023
$1.7M
Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infectionsK08AI130381 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARLIN, AARON F. · 2019 to 2023
$1.0M
Exploiting Natural Genetic and Organismic Variation to Identify the DNA Motifs Regulating TranscriptionR00GM135515 · NIGMS · WASHINGTON STATE UNIVERSITY · PI DUTTKE, SASCHA H. · 2022 to 2024
$747k
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
NCI NIH HHS R01 CA238662NCI NIH HHS R35 CA197718NIAID NIH HHS K08 AI130381NIAID NIH HHS R01 AI116813NIAID NIH HHS R01 AI153500NIAID NIH HHS R21 AI129846NIAID NIH HHS R21 AI140063NIGMS NIH HHS K99 GM135515NIGMS NIH HHS R00 GM135515NIGMS NIH HHS R01 GM134366NIGMS NIH HHS T32 GM008666NIH HHS S10 OD026929NINDS NIH HHS R01 NS103434NINDS NIH HHS R01 NS106387
6 · The paper itself

Abstract

The emergence of Zika virus (ZIKV) as a global health threat has highlighted the unmet need for ZIKV-specific vaccines and antiviral treatments. ZIKV infects dendritic cells (DC), which have pivotal functions in activating innate and adaptive antiviral responses; however, the mechanisms by which DC function is subverted to establish ZIKV infection are unclear. Here we develop a genomics profiling method that enables discrete analysis of ZIKV-infected versus neighboring, uninfected primary human DCs to increase the sensitivity and specificity with which ZIKV-modulated pathways can be identified. The results show that ZIKV infection specifically increases the expression of genes enriched for lipid metabolism-related functions. ZIKV infection also increases the recruitment of sterol regulatory element-binding protein (SREBP) transcription factors to lipid gene promoters, while pharmacologic inhibition or genetic silencing of SREBP2 suppresses ZIKV infection of DCs. Our data thus identify SREBP2-activated transcription as a mechanism for promoting ZIKV infection amenable to therapeutic targeting.

Indexed as

Zika VirusZika Virus InfectionAntiviral AgentsDendritic CellsHumansLipidsTranscription, GeneticAntiviral AgentsLipids

Identifiers

PMID36097162
PMCPMC9465152
OpenAlexW4295497277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.